Literature DB >> 23873935

A pre-microRNA-149 (miR-149) genetic variation affects miR-149 maturation and its ability to regulate the Puma protein in apoptosis.

Su-Ling Ding1, Jian-Xun Wang, Jian-Qin Jiao, Xin Tu, Qing Wang, Fang Liu, Qian Li, Jie Gao, Qun-Yong Zhou, Dong-Feng Gu, Pei-Feng Li.   

Abstract

MicroRNAs (miRNAs) are small, single-stranded, noncoding RNAs that function as negative regulators of gene expression. They are transcribed from endogenous DNA and form hairpin structures (termed as pre-miRNAs) that are processed to form mature miRNAs. It remains largely unknown as to the molecular consequences of the natural genetic variation in pre-miRNAs. Here, we report that an A→G polymorphism (rs71428439) is located in Homo sapiens miR-149 stem-loop region. This polymorphism results in a change in the structure of the miR-149 precursor. Our results showed that the genotype distribution of this polymorphism in myocardial infarction cases was significantly different from that in the control subjects. We examined the biological significance of this polymorphism on the production of mature miR-149, and we observed that the G-allelic miR-149 precursor displayed a lower production of mature miR-149 compared with the A-allelic one. Further investigations disclosed that miR-149 could withstand mitochondrial fission and apoptosis through targeting the pro-apoptotic factor p53-up-regulated modulator of apoptosis (Puma). Enforced expression of miR-149 promoted cell survival, whereas knockdown of miR-149 rendered cells to be sensitive to apoptotic stimulation. Intriguingly, the A to G variation led pre-miR-149 to elicit an attenuated effect on the inhibition of mitochondrial fission and apoptosis. Finally, this polymorphism exerts its influence on cardiac function in the mouse model of myocardial infarction. These data suggest that this polymorphism in the miR-149 precursor may result in important phenotypic traits of myocardial infarction. Our findings warrant further investigations on the relationship between miR-149 polymorphism and myocardial infarction.

Entities:  

Keywords:  Cardiovascular Disease; Genetic Polymorphism; Human Genetics; MicroRNA; Mitochondrial Apoptosis

Mesh:

Substances:

Year:  2013        PMID: 23873935      PMCID: PMC3772234          DOI: 10.1074/jbc.M112.440453

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion.

Authors:  Ambrus Toth; John R Jeffers; Philip Nickson; Jiang-Yong Min; James P Morgan; Gerard P Zambetti; Peter Erhardt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-06       Impact factor: 4.733

3.  Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs.

Authors:  Yingqing Sun; Seongjoon Koo; Neill White; Eigen Peralta; Christine Esau; Nicholas M Dean; Ranjan J Perera
Journal:  Nucleic Acids Res       Date:  2004-12-22       Impact factor: 16.971

4.  Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction.

Authors:  Marcus Fischer; Ulrich Broeckel; Stephan Holmer; Andrea Baessler; Christian Hengstenberg; Bjoern Mayer; Jeanette Erdmann; Gernot Klein; Guenter Riegger; Howard J Jacob; Heribert Schunkert
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

5.  Genetic--epidemiologic study of early-onset ischemic heart disease.

Authors:  J J Nora; R H Lortscher; R D Spangler; A H Nora; W J Kimberling
Journal:  Circulation       Date:  1980-03       Impact factor: 29.690

6.  Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling.

Authors:  Kengo F Kusano; Roberto Pola; Toshinori Murayama; Cynthia Curry; Atsuhiko Kawamoto; Atsushi Iwakura; Satoshi Shintani; Masaaki Ii; Jun Asai; Tengiz Tkebuchava; Tina Thorne; Hideya Takenaka; Ryuichi Aikawa; David Goukassian; Patrick von Samson; Hiromichi Hamada; Young-sup Yoon; Marcy Silver; Elizabeth Eaton; Hong Ma; Lindsay Heyd; Marianne Kearney; William Munger; Jeffery A Porter; Raj Kishore; Douglas W Losordo
Journal:  Nat Med       Date:  2005-10-23       Impact factor: 53.440

7.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

8.  The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis.

Authors:  S Frank; B Gaume; E S Bergmann-Leitner; W W Leitner; E G Robert; F Catez; C L Smith; R J Youle
Journal:  Dev Cell       Date:  2001-10       Impact factor: 12.270

9.  Genetic susceptibility to death from coronary heart disease in a study of twins.

Authors:  M E Marenberg; N Risch; L F Berkman; B Floderus; U de Faire
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

10.  The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.

Authors:  Hsi-Feng Tu; Chung-Ji Liu; Che-Lun Chang; Pei-Wen Wang; Shou-Yen Kao; Cheng-Chieh Yang; En-Hao Yu; Shu-Chun Lin; Kuo-Wei Chang
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more
  29 in total

Review 1.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

Review 2.  Regulatory non-coding RNAs in acute myocardial infarction.

Authors:  Yuan Guo; Fei Luo; Qiong Liu; Danyan Xu
Journal:  J Cell Mol Med       Date:  2016-11-23       Impact factor: 5.310

Review 3.  Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases.

Authors:  Yanhan Dong; Cuiyun Liu; Yanfang Zhao; Murugavel Ponnusamy; Peifeng Li; Kun Wang
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

4.  The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Lin Jiang; Chaofu Wang; Canlin Sun; Yumin Xu; Zhongqi Ding; Xueling Zhang; Junxing Huang; Hong Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Genetic variants in microRNA genes and targets associated with cardiovascular disease risk factors in the African-American population.

Authors:  Chang Li; Megan L Grove; Bing Yu; Barbara C Jones; Alanna Morrison; Eric Boerwinkle; Xiaoming Liu
Journal:  Hum Genet       Date:  2017-12-20       Impact factor: 4.132

6.  Low MiR-149 expression is associated with unfavorable prognosis and enhanced Akt/mTOR signaling in glioma.

Authors:  Liang Xue; Yi Wang; Shuyuan Yue; Jianning Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  A Rapid, High-Quality, Cost-Effective, Comprehensive and Expandable Targeted Next-Generation Sequencing Assay for Inherited Heart Diseases.

Authors:  Kitchener D Wilson; Peidong Shen; Eula Fung; Ioannis Karakikes; Angela Zhang; Kolsoum InanlooRahatloo; Justin Odegaard; Karim Sallam; Ronald W Davis; George K Lui; Euan A Ashley; Curt Scharfe; Joseph C Wu
Journal:  Circ Res       Date:  2015-08-11       Impact factor: 17.367

8.  MIR4532 gene variant rs60432575 influences the expression of KCNJ11 and the sulfonylureas-stimulated insulin secretion.

Authors:  Zhang-Ren Chen; Fa-Zhong He; Mou-Ze Liu; Jin-Lei Hu; Heng Xu; Hong-Hao Zhou; Wei Zhang
Journal:  Endocrine       Date:  2018-09-21       Impact factor: 3.633

Review 9.  Regulation and functions of MicroRNA-149 in human cancers.

Authors:  Yingru Zhi; Hao Zhou; Abudoureyimu Mubalake; Ying Chen; Bei Zhang; Kai Zhang; Xiaoyuan Chu; Rui Wang
Journal:  Cell Prolif       Date:  2018-07-12       Impact factor: 6.831

10.  Pre-miR-149 rs71428439 polymorphism is associated with increased cancer risk and AKT1/cyclinD1 signaling in hepatocellular carcinoma.

Authors:  Jiantao Wu; Shemin Lv; Jianbo An; Chunhui Lu
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.